Ledger.Open graph →
SEC Form D · filed May 24, 2023

SYNNOVATION THERAPEUTICS, INC

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Liangxing Wu · Wilmington, DEExec · DirectorTing Feng · Wilmington, DEDirectorWenqing Yao · Wilmington, DEExec · DirectorReid Huber · Boston, MADirectorLiangxing Wu · Wilmington, DEExec · DirectorReid Huber · Boston, MADirectorTing Feng · Wilmington, DEDirectorWenqing Yao · Wilmington, DEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗